{"id":"https://openalex.org/W4411698166","doi":"https://doi.org/10.32383/appdr/204685","title":"Preparation and Stability Evaluation of Mesna Oral Solution From Commercially Available Tablets for Pediatric Patients","display_name":"Preparation and Stability Evaluation of Mesna Oral Solution From Commercially Available Tablets for Pediatric Patients","publication_year":2025,"publication_date":"2025-06-24","ids":{"openalex":"https://openalex.org/W4411698166","doi":"https://doi.org/10.32383/appdr/204685"},"language":"en","primary_location":{"id":"doi:10.32383/appdr/204685","doi":"https://doi.org/10.32383/appdr/204685","is_oa":true,"landing_page_url":"https://doi.org/10.32383/appdr/204685","pdf_url":"https://doi.org/10.32383/appdr/204685","source":{"id":"https://openalex.org/S157208032","display_name":"Acta Poloniae Pharmaceutica - Drug Research","issn_l":"0001-6837","issn":["0001-6837","2353-5288"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4322807899","host_organization_name":"Polish Pharmaceutical Society","host_organization_lineage":["https://openalex.org/P4322807899"],"host_organization_lineage_names":["Polish Pharmaceutical Society"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Poloniae Pharmaceutica - Drug Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.32383/appdr/204685","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056727281","display_name":"Samiah A. Alhabardi","orcid":"https://orcid.org/0000-0001-8077-9103","observed_orcids":["https://orcid.org/0000-0001-8077-9103"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Samiah Alhabardi","raw_affiliation_strings":["Department of of Pharmaceutics , Faculty of Pharmacy , King Saud University , Riyadh , Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-8077-9103","affiliations":[{"raw_affiliation_string":"Department of of Pharmaceutics , Faculty of Pharmacy , King Saud University , Riyadh , Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102630163","display_name":"Norah Oudah Alotaibi","orcid":"https://orcid.org/0009-0000-0175-3336","observed_orcids":["https://orcid.org/0009-0000-0175-3336"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Norah Alotaibi","raw_affiliation_strings":["Department of of Pharmaceutics , Faculty of Pharmacy , King Saud University , Riyadh , Saudi Arabia"],"raw_orcid":"https://orcid.org/0009-0000-0175-3336","affiliations":[{"raw_affiliation_string":"Department of of Pharmaceutics , Faculty of Pharmacy , King Saud University , Riyadh , Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055635576","display_name":"Alanood S. Almurshedi","orcid":"https://orcid.org/0000-0001-7736-6279","observed_orcids":["https://orcid.org/0000-0001-7736-6279"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Alanood Almurshedi","raw_affiliation_strings":["\u00b3Department of Botany and Microbiology , Faculty of Science , King Saud University , Riyadh , Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-7736-6279","affiliations":[{"raw_affiliation_string":"\u00b3Department of Botany and Microbiology , Faculty of Science , King Saud University , Riyadh , Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016647291","display_name":"Basmah Nasser Aldosari","orcid":"https://orcid.org/0000-0003-4398-2510","observed_orcids":["https://orcid.org/0000-0003-4398-2510"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Basmah Aldosari","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4398-2510","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029808986","display_name":"Noura S. Aldosari","orcid":"https://orcid.org/0009-0006-4716-3810","observed_orcids":["https://orcid.org/0009-0006-4716-3810"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noura Aldosari","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-4716-3810","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060946577","display_name":"Wedad S. Sarawi","orcid":"https://orcid.org/0000-0001-6376-9464","observed_orcids":["https://orcid.org/0000-0001-6376-9464"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Wedad Sarawi","raw_affiliation_strings":["Department of Pharmacology and Toxicology , Faculty of Pharmacy , King Saud University , Riyadh , Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-6376-9464","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology , Faculty of Pharmacy , King Saud University , Riyadh , Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18362043,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"1","first_page":"133","last_page":"143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mesna","display_name":"mesna","score":0.9879999756813049},{"id":"https://openalex.org/keywords/oral-solution","display_name":"oral solution","score":0.847000002861023},{"id":"https://openalex.org/keywords/pediatric-drug-formulation","display_name":"pediatric formulations","score":0.6740000247955322},{"id":"https://openalex.org/keywords/extemporaneous-compounding","display_name":"extemporaneous compounding","score":0.9639999866485596},{"id":"https://openalex.org/keywords/citric-acid","display_name":"citric acid","score":0.7549999952316284},{"id":"https://openalex.org/keywords/urotoxicity","display_name":"urotoxicity","score":0.671999990940094},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.8320000171661377},{"id":"https://openalex.org/keywords/physicochemical-stability","display_name":"physicochemical stability","score":0.7440000176429749},{"id":"https://openalex.org/keywords/microbiological-analysis","display_name":"microbiological analysis","score":0.7699999809265137},{"id":"https://openalex.org/keywords/drug-solubility","display_name":"drug solubility","score":0.6119999885559082},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C2780376820","wikidata":"https://www.wikidata.org/wiki/Q424997","display_name":"Mesna","level":5,"score":0.844869077205658},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4478663504123688},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.33756768703460693},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.11926966905593872},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.05532640218734741},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.32383/appdr/204685","doi":"https://doi.org/10.32383/appdr/204685","is_oa":true,"landing_page_url":"https://doi.org/10.32383/appdr/204685","pdf_url":"https://doi.org/10.32383/appdr/204685","source":{"id":"https://openalex.org/S157208032","display_name":"Acta Poloniae Pharmaceutica - Drug Research","issn_l":"0001-6837","issn":["0001-6837","2353-5288"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4322807899","host_organization_name":"Polish Pharmaceutical Society","host_organization_lineage":["https://openalex.org/P4322807899"],"host_organization_lineage_names":["Polish Pharmaceutical Society"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Poloniae Pharmaceutica - Drug Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.32383/appdr/204685","doi":"https://doi.org/10.32383/appdr/204685","is_oa":true,"landing_page_url":"https://doi.org/10.32383/appdr/204685","pdf_url":"https://doi.org/10.32383/appdr/204685","source":{"id":"https://openalex.org/S157208032","display_name":"Acta Poloniae Pharmaceutica - Drug Research","issn_l":"0001-6837","issn":["0001-6837","2353-5288"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4322807899","host_organization_name":"Polish Pharmaceutical Society","host_organization_lineage":["https://openalex.org/P4322807899"],"host_organization_lineage_names":["Polish Pharmaceutical Society"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Poloniae Pharmaceutica - Drug Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321145","display_name":"King Saud University","ror":"https://ror.org/02f81g417"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4411698166.pdf","grobid_xml":"https://content.openalex.org/works/W4411698166.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W1966053260","https://openalex.org/W2472755809","https://openalex.org/W2169716228","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W4396573737","https://openalex.org/W1995515455"],"abstract_inverted_index":{"This":[0,139],"research":[1],"focused":[2],"on":[3],"the":[4,32,57,84,88,109,134,137,142],"formulation":[5,53],"and":[6,29,50,78,103,121],"evaluation":[7],"of":[8,13,87,136,144],"a":[9,15,92,151],"pediatric":[10,36,155],"oral":[11,43,110,148],"solution":[12,44,90,111,149],"mesna,":[14],"chemoprotective":[16],"agent":[17],"used":[18],"to":[19,47,59,164],"mitigate":[20],"urotoxicity":[21],"associated":[22],"with":[23,116],"chemotherapy":[24],"drugs":[25],"such":[26,97],"as":[27,75,98,150],"ifosfamide":[28],"cyclophosphamide.":[30],"Given":[31],"challenges":[33,162],"faced":[34],"by":[35],"patients":[37],"in":[38,119],"swallowing":[39],"tablets,":[40],"an":[41,76,145],"extemporaneous":[42,146],"was":[45],"developed":[46],"improve":[48],"accessibility":[49],"compliance.":[51],"The":[52,81],"process":[54],"involved":[55],"adjusting":[56],"pH":[58,101,120],"approximately":[60],"3":[61],"using":[62],"citric":[63],"acid,":[64],"which":[65],"not":[66],"only":[67],"enhanced":[68],"mesna's":[69],"water":[70],"solubility":[71],"but":[72],"also":[73],"acted":[74],"antioxidant":[77],"flavor":[79],"enhancer.":[80],"study":[82,140],"assessed":[83],"physicochemical":[85,114],"stability":[86,126],"mesna":[89,147],"over":[91],"90-day":[93],"period,":[94],"evaluating":[95],"parameters":[96],"color":[99],"stability,":[100],"consistency,":[102],"drug":[104,122],"content.":[105],"Results":[106],"demonstrated":[107],"that":[108],"maintained":[112],"its":[113],"properties,":[115],"minimal":[117],"changes":[118],"concentration,":[123],"indicating":[124],"good":[125],"under":[127],"refrigerated":[128],"conditions.":[129],"Additionally,":[130],"microbiological":[131],"evaluations":[132],"confirmed":[133],"safety":[135],"formulation.":[138],"highlights":[141],"potential":[143],"viable":[152],"alternative":[153],"for":[154],"patients,":[156],"ensuring":[157],"effective":[158],"treatment":[159],"while":[160],"addressing":[161],"related":[163],"medication":[165],"administration":[166],"or":[167],"shortage.":[168]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2025-10-10T00:00:00"}